Cheng‐Po Hu
- Co-authors
- Chung-Ming ChangChungming ChangWing‐Yiu LuiSzecheng J. LoJen‐Hwey ChiuChen‐Kung ChouSue‐Jane LinAh‐Kau Ng
- Topics
- Hepatitis B Virus Studies (9 papers)Immunotherapy and Immune Responses (5 papers)Hepatitis C virus research (5 papers)
- Cited by
- HepatologyOncologyImmunology
In The Last Decade
Cheng‐Po Hu
27 papers receiving 686 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 283
- Epidemiology 217
- Oncology 182
- Hepatology 148
- Immunology 136
Countries citing papers authored by Cheng‐Po Hu
This map shows the geographic impact of Cheng‐Po Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Po Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Po Hu more than expected).
Fields of papers citing papers by Cheng‐Po Hu
This network shows the impact of papers produced by Cheng‐Po Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Po Hu. The network helps show where Cheng‐Po Hu may publish in the future.
Co-authorship network of co-authors of Cheng‐Po Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Po Hu. A scholar is included among the top collaborators of Cheng‐Po Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Po Hu. Cheng‐Po Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 58 | |
| 3 | 42 | |
| 4 | 7 | |
| 5 | 68 | |
| 6 | 2 | |
| 7 | Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads. | 5 |
| 8 | 58 | |
| 9 | 43 | |
| 10 | 6 | |
| 11 | 5 | |
| 12 | 34 | |
| 13 | 1 | |
| 14 | 5 | |
| 15 | 26 | |
| 16 | 15 | |
| 17 | 12 | |
| 18 | 29 | |
| 19 | 6 | |
| 20 | 56 |
About Cheng‐Po Hu
Cheng‐Po Hu is a scholar working on Hepatology, Immunology and Epidemiology, having authored 27 papers that have together received 699 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), Immunotherapy and Immune Responses (5 papers) and Hepatitis C virus research (5 papers). The work is most often cited by research in Hepatology (148 citations), Oncology (182 citations) and Immunology (136 citations). Cheng‐Po Hu has collaborated with scholars based in Taiwan, China and Czechia. Frequent co-authors include Chung-Ming Chang, Chungming Chang, Wing‐Yiu Lui, Szecheng J. Lo, Jen‐Hwey Chiu, Chen‐Kung Chou, Sue‐Jane Lin, Ah‐Kau Ng, Shou‐Hwa Han and Fang‐Ku P’eng. Their work appears in journals such as Nucleic Acids Research, The Journal of Immunology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.